Literature DB >> 12085349

Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes.

Hidenari Nagai1, Katsuhiko Matsumaru, Guoping Feng, Neil Kaplowitz.   

Abstract

The effect of reduced glutathione (GSH) depletion by acetaminophen (APAP), diethylmaleate (DEM), or phorone on the mode of cell death and susceptibility to tumor necrosis factor (TNF)-induced cell death was studied in cultured mouse hepatocytes. Dose-dependent necrosis was the exclusive mode of cell death with APAP alone, but the addition of TNF-alpha induced a switch to about half apoptosis without changing total loss of viability. This effect was seen at 1 and 5 mmol/L but was inhibited at 10 and 20 mmol/L APAP. The switch to apoptosis was associated with increased caspase activities, release of cytochrome c, and DNA laddering and was inhibited by caspase inhibitors. DEM and phorone also induced dose-dependent necrosis. Treatment with TNF-alpha under these conditions lead to incremental cell death in the form of apoptosis at 0.25 and 0.5 mmol/L DEM and 0.1 and 0.2 mmol/L phorone. At 1.0 and 2.0 mmol/L DEM and 0.5 mmol/L phorone, 90% to 100% necrosis was observed with resistance to TNF-alpha effects. The apoptosis with TNF-alpha plus DEM was confirmed by DNA laddering and inhibition by caspase inhibitors. However, in the presence of caspase inhibitors, the increment in cell death induced by TNF-alpha persisted as an increase in necrosis. A combination of antioxidants, vitamin E, and butylated hydroxytoluene (BHT) markedly inhibited necrosis induced by APAP or DEM alone, but the sensitization to TNF-alpha-induced apoptosis was unaffected. GSH monoethylester (GSH-EE) protected against necrosis and apoptosis. In conclusion, depletion of GSH by APAP, DEM, or phorone causes oxidative stress-induced necrosis and sensitizes to an oxidative stress independent TNF-alpha-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085349     DOI: 10.1053/jhep.2002.33995

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents.

Authors:  G Kaur; N Tirkey; S Bharrhan; V Chanana; P Rishi; K Chopra
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.

Authors:  Daniel James Antoine; Dominic P Williams; Anja Kipar; Hugh Laverty; B Kevin Park
Journal:  Mol Med       Date:  2010-08-27       Impact factor: 6.354

3.  The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes.

Authors:  Hui-Min Yan; Anup Ramachandran; Mary Lynn Bajt; John J Lemasters; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2010-07-08       Impact factor: 4.849

4.  Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression.

Authors:  Marko Duvnjak; Neven Barsić; Vedran Tomasić; Ivan Lerotić
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

5.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

6.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 7.  Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.

Authors:  Derick Han; Lily Dara; Sanda Win; Tin Aung Than; Liyun Yuan; Sadeea Q Abbasi; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Trends Pharmacol Sci       Date:  2013-02-28       Impact factor: 14.819

Review 8.  Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.

Authors:  Hartmut Jaeschke; C David Williams; Mitchell R McGill; Yuchao Xie; Anup Ramachandran
Journal:  Food Chem Toxicol       Date:  2013-01-22       Impact factor: 6.023

Review 9.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

Review 10.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.